Postoperative Delirium in Patients Undergoing Radical Cystectomy
キーワード
概要
説明
With voluntary participation, this study requires participants to complete a self-administered cognitive evaluation (SAGE) before surgery to assess baseline cognitive impairment and early dementia; vital signs will be documented prior to surgery. During surgery, participants will receive a standardized general anesthesia regimen as described in the protocol. Several parameters will be measured during surgery, including bispectral monitoring to measure processed EEG. After surgery, fitness for cognitive evaluation will be determined by the Richmond Agitation-Sedation Scale (RASS) scale, and then emergence delirium will be assessed using the CAM-ICU scale. Fitness for discharge from PACU will be determined by an Aldrete score of 9 or more. Postoperative pain will be assessed using the 11-point Numeric Rating Scale (NRS-11). Postoperative nausea and vomiting (PONV) level will also be documented. Postoperative Delirium (POD) assessment will be achieved by administering the memorial delirium assessment scale (MDAS) twice a day starting on day 1 through day 3 postoperatively. Pain NRS-11 score and PONV levels will also be documented at each visit. For microRNA testing, blood probes will be collected in 5mL purple top tube at surgical preadmission and post-surgery days one, two and three. Risks associated with participating in this study include normal risk associated with having surgery and general anesthesia; no greater than minimal risk is associated with blood collection. For the participant, there are no immediate anticipated benefits for participating in this study. The importance of the knowledge that is expected to result includes lower post-operative complications as a result of post-operative delirium, faster recovery, and shorter hospital stay.
日付
| 最終確認済み: | 03/31/2017 |
| 最初に提出された: | 04/04/2017 |
| 提出された推定登録数: | 04/25/2017 |
| 最初の投稿: | 04/26/2017 |
| 最終更新が送信されました: | 04/25/2017 |
| 最終更新日: | 04/26/2017 |
| 実際の研究開始日: | 07/31/2016 |
| 一次完了予定日: | 12/31/2017 |
| 研究完了予定日: | 12/31/2017 |
状態または病気
介入/治療
Behavioral: Subjects undergoing radical cystectomy
Procedure: Subjects undergoing radical cystectomy
Other: Subjects undergoing radical cystectomy
段階
アームグループ
| 腕 | 介入/治療 |
|---|---|
| Other: Subjects undergoing radical cystectomy Subjects involved in the study will be evaluated with various non-invasive assessments including the Richmond Agitation-Sedation Scale, pain assessments on a Numeric Rating Scale (NRS-11), and CAM-ICU scale. Blood draws will also take place in order to perform microRNA testing in all subjects participating in the trial. Standardized anesthetic care as described by the approved protocol will be followed for each subject included in this trial. | Behavioral: Subjects undergoing radical cystectomy These cognitive assessments will be utilized during the study to evaluate cognitive levels comparing prior to surgery and post-operatively in order to determine if the subject is delirious. BIS monitoring will be utilized for all subjects. |
適格基準
| 研究の対象となる年齢 | 18 Years に 18 Years |
| 研究に適格な性別 | All |
| 健康なボランティアを受け入れる | はい |
| 基準 | Inclusion Criteria: - Male or female, 18 years of age and older - ASA II or III - Capable of and willing to consent - Participants literate in English language Exclusion Criteria: - ASA IV or V - Patients with severe visual or auditory impairment - Inability to read and/or write in English - Presence of a clinically diagnosed major psychiatric condition such as bipolar disorder, uncontrolled major depression, schizophrenia - Dementia of Alzheimer's type - Parkinson's disease - Multiple Sclerosis (MS) - Vascular dementia |
結果
主な結果の測定
1. Post-operative delirium [up to 3 days post-operatively]
二次的な結果の測定
1. microRNA expression [up to 3 days post-operatively]
